Physician

Hematology

Dr. James E. Krook, MD

James Krook is an expert in the field of Hematology. James Krook has written publications. She has 22 publications published with PubMed. The lastest paper is: 'Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of ...'

Publications

Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of ...
Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer.
Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer.
A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.
Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials.
Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastat...
Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly.
Phase II trial of dolastatin-10 in patients with advanced breast cancer.
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both.
A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer.
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group.
Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma.
Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity mon...
Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanoma.
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
Prevalence and Prognostic Significance of Neuroendocrine Differentiation in Colorectal Carcinomas.

Doctors Specialties

Hematology

Accepted Insurances

Education

Duke University Hospital

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Pritesh V. Lohar, MD
	Dr. Basem S. Goueli, MD This Doctor is OpenDoctor Recommended.
	Dr. Jay D. Baker, DO
	Dr. Steven A. Kuross, MD This Doctor is OpenDoctor Recommended.
	Dr. Tanya L. Repka, MD This Doctor is OpenDoctor Recommended.
	Dr. Brad J. Davis, MD
	Dr. Benjamin R. Koch, MD This Doctor is OpenDoctor Recommended.